What side effects were most frequently reported with the original formulation of mirikizumab (Omvoh)?

The most frequently reported side effects with the original mirikizumab (Omvoh) formulation were upper respiratory tract infections (9.8%, most frequently nasopharyngitis), headache (3.2%), rash (1.3%) and injection-site reactions (10.8% during maintenance treatment).